{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T05:51:27Z","timestamp":1791697887392,"version":"4.3.4"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4,15]]},"DOI":"10.1097\/qai.0000000000000082","type":"journal-article","created":{"date-parts":[[2013,12,9]],"date-time":"2013-12-09T09:18:52Z","timestamp":1386580732000},"page":"587-596","source":"Crossref","is-referenced-by-count":67,"title":["Increase in Single-Tablet Regimen Use and Associated Improvements in Adherence-Related Outcomes in HIV-Infected Women"],"prefix":"10.1097","volume":"65","author":[{"given":"David B.","family":"Hanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A.","family":"Hessol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth T.","family":"Golub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Cocohoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mardge H.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra M.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey E.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Anastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210131","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/00002030-200106150-00015","article-title":". Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.","volume":"15","author":"Bangsberg","year":"2001","journal-title":"AIDS"},{"key":"R2-12-20210131","doi-asserted-by":"crossref","first-page":"564","DOI":"10.7326\/0003-4819-146-8-200704170-00007","article-title":". Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.","volume":"146","author":"Nachega","year":"2007","journal-title":"Ann Intern Med"},{"key":"R3-12-20210131","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/QAI.0B013E31822D490A","article-title":". Depression and HIVAIDS treatment nonadherence: a review and meta-analysis.","volume":"58","author":"Gonzalez","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R4-12-20210131","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.lfs.2010.09.025","article-title":"Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals.","volume":"88","author":"Lucas","year":"2011","journal-title":"Life Sci"},{"key":"R5-12-20210131","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1086\/522762","article-title":". Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women.","volume":"45","author":"Lazo","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R6-12-20210131","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/1874613601206010213","article-title":". Use of and adherence to antiretroviral therapy in a large U.S. sample of HIV-infected adults in care, 2007-2008.","volume":"6","author":"Beer","year":"2012","journal-title":"Open AIDS J"},{"key":"R7-12-20210131","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/QAI.0b013e31825db0bd","article-title":". RacialEthnic disparities in ART adherence in the United States: findings from the MACH14 study.","volume":"60","author":"Simoni","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R8-12-20210131","doi-asserted-by":"crossref","first-page":"e31591","DOI":"10.1371\/journal.pone.0031591","article-title":". Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States.","volume":"7","author":"Sax","year":"2012","journal-title":"PLoS One"},{"key":"R9-12-20210131","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1086\/596482","article-title":". Better adherence with once-daily antiretroviral regimens: a meta-analysis.","volume":"48","author":"Parienti","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R10-12-20210131","first-page":"135","article-title":"An update on the use of Atripla in the treatment of HIV in the United States.","volume":"2","author":"Horberg","year":"2010","journal-title":"HIV AIDS (Auckl)"},{"key":"R11-12-20210131","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bcp.2012.03.024","article-title":"Where rilpivirine meets with tenofovir, the start of a new anti-HIV drug combination era.","volume":"84","author":"De Clercq","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"R12-12-20210131","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1517\/13543784.2012.685653","article-title":"The elvitegravir Quad pill: the first once-daily dual-target anti-HIV tablet.","volume":"21","author":"Marchand","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"R15-12-20210131","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/QAI.0b013e3181a572cf","article-title":". Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients.","volume":"51","author":"Dejesus","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R16-12-20210131","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/apc.2009.0259","article-title":". Patient-reported outcomes in virologically suppressed, HIV-1-Infected subjects after switching to a simplified, single-tablet regimen of efavirenz, emtricitabine, and tenofovir DF.","volume":"24","author":"Hodder","year":"2010","journal-title":"AIDS Patient Care STDS"},{"key":"R17-12-20210131","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1097\/QAD.0b013e328340a209","article-title":". A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV homeless and marginally housed people.","volume":"24","author":"Bangsberg","year":"2010","journal-title":"AIDS"},{"key":"R18-12-20210131","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11904-011-0098-0","article-title":". Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011.","volume":"8","author":"Puskas","year":"2011","journal-title":"Curr HIVAIDS Rep"},{"key":"R19-12-20210131","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1086\/423181","article-title":". Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Womens Interagency HIV Study.","volume":"39","author":"Silverberg","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R20-12-20210131","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/1054773805275122","article-title":". Sleep disturbance and depression as barriers to adherence.","volume":"14","author":"Phillips","year":"2005","journal-title":"Clin Nurs Res"},{"key":"R21-12-20210131","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/apc.2008.0161","article-title":". Association of child care burden and household composition with adherence to highly active antiretroviral therapy in the Womens Interagency HIV Study.","volume":"23","author":"Merenstein","year":"2009","journal-title":"AIDS Patient Care STDS"},{"key":"R22-12-20210131","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00001648-199803000-00004","article-title":". The Womens Interagency HIV Study.","volume":"9","author":"Barkan","year":"1998","journal-title":"Epidemiology"},{"key":"R23-12-20210131","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1128\/CDLI.12.9.1013-1019.2005","article-title":". The Womens Interagency HIV Study: an observational cohort brings clinical sciences to the bench.","volume":"12","author":"Bacon","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"R25-12-20210131","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/apc.2007.0101","article-title":". Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.","volume":"22","author":"Horberg","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"R26-12-20210131","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/09540120050042891","article-title":". Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments.","volume":"12","author":"Chesney","year":"2000","journal-title":"AIDS Care"},{"key":"R27-12-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-133-1-200007040-00004","article-title":". Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.","volume":"133","author":"Paterson","year":"2000","journal-title":"Ann Intern Med"},{"key":"R28-12-20210131","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s10461-011-9951-9","article-title":". Medication adherence: tailoring the analysis to the data.","volume":"15","author":"Saberi","year":"2011","journal-title":"AIDS Behav"},{"key":"R29-12-20210131","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-6405-3-6","article-title":". Assessing the effect of HAART on change in quality of life among HIV-infected women.","volume":"3","author":"Liu","year":"2006","journal-title":"AIDS Res Ther"},{"key":"R30-12-20210131","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00042560-199503010-00006","article-title":". Derivation and properties of a brief health status assessment instrument for use in HIV disease.","volume":"8","author":"Bozzette","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R31-12-20210131","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.","volume":"41","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"R32-12-20210131","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D Scale: a self-report depression scale for research in the general population.","volume":"1","author":"Radloff","year":"1977","journal-title":"Appl Psychol Meas"},{"key":"R33-12-20210131","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1742-7843.2006.pto_293.x","article-title":"Indications for propensity scores and review of their use in pharmacoepidemiology.","volume":"98","author":"Glynn","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R34-12-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/09-STS313","article-title":"Matching methods for causal inference: a review and a look forward.","volume":"25","author":"Stuart","year":"2010","journal-title":"Stat Sci"},{"key":"R35-12-20210131","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/aje\/kwf215","article-title":". Statistical analysis of correlated data using generalized estimating equations: an orientation.","volume":"157","author":"Hanley","year":"2003","journal-title":"Am J Epidemiol"},{"key":"R36-12-20210131","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.annepidem.2003.09.012","article-title":". Use of the case-crossover design to study prolonged drug exposures and insidious outcomes.","volume":"14","author":"Wang","year":"2004","journal-title":"Ann Epidemiol"},{"key":"R37-12-20210131","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/pan\/mpl013","article-title":". Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference.","volume":"15","author":"Ho","year":"2007","journal-title":"Polit Anal"},{"key":"R38-12-20210131","first-page":"115","article-title":". One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects.","volume":"4","author":"Airoldi","year":"2010","journal-title":"Patient Prefer Adherence"},{"key":"R39-12-20210131","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1310\/98B3-PWG8-PMYW-W5BP","article-title":". Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patients.","volume":"3","author":"Maggiolo","year":"2002","journal-title":"HIV Clin Trials"},{"key":"R40-12-20210131","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/0003-4819-157-5-201209040-00005","article-title":". U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.","volume":"157","author":"Althoff","year":"2012","journal-title":"Ann Intern Med"},{"key":"R41-12-20210131","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/QAI.0b013e318236f7d2","article-title":". Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention.","volume":"59","author":"Mugavero","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R42-12-20210131","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/QAI.0b013e318273762f","article-title":". Measuring retention in HIV care: the elusive gold standard.","volume":"61","author":"Mugavero","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R43-12-20210131","first-page":"168","article-title":"Once-daily single-tablet regimens: a long and winding road to excellence in antiretroviral treatment.","volume":"14","author":"Llibre","year":"2012","journal-title":"AIDS Rev"},{"key":"R44-12-20210131","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1310\/hct1205-244","article-title":". Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naive, HIV patients.","volume":"12","author":"Buscher","year":"2011","journal-title":"HIV Clin Trials"},{"key":"R45-12-20210131","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1089\/apc.2007.0229","article-title":". Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards.","volume":"22","author":"Deschamps","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"R46-12-20210131","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-156-11-201206050-00419","article-title":". Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel.","volume":"156","author":"Thompson","year":"2012","journal-title":"Ann Intern Med"},{"key":"R47-12-20210131","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1345\/aph.1P587","article-title":"Levels of adherence required for virologic suppression among newer antiretroviral medications.","volume":"45","author":"Kobin","year":"2011","journal-title":"Ann Pharmacother"},{"key":"R48-12-20210131","doi-asserted-by":"crossref","first-page":"580","DOI":"10.7326\/0003-4819-157-8-201210160-00013","article-title":"Rethinking adherence.","volume":"157","author":"Steiner","year":"2012","journal-title":"Ann Intern Med"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAI.0000000000000082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:37:00Z","timestamp":1620970620000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201404150-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,15]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0000000000000082","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4,15]]}}}